Filing Details

Accession Number:
0001232524-14-000014
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-03-03 19:10:02
Reporting Period:
2014-02-27
Filing Date:
2014-03-03
Accepted Time:
2014-03-03 19:10:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1232524 Jazz Pharmaceuticals Plc JAZZ Pharmaceutical Preparations (2834) 981032470
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1512984 J. Russell Cox C/o Jazz Pharmaceuticals Plc
Connaught House, 1 Burlington Rd, Fl. 4
Dublin 4 L2
Evp & Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2014-02-27 3,000 $166.12 51,024 No 4 S Direct
Ordinary Shares Disposition 2014-02-27 1,000 $160.00 50,024 No 4 S Direct
Ordinary Shares Acquisiton 2014-02-27 10,000 $0.00 60,024 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Nonstatutory Stock Option (right to buy) Acquisiton 2014-02-27 19,400 $0.00 19,400 $166.62
Ordinary Shares Incentive Stock Option (right to buy) Acquisiton 2014-02-27 600 $0.00 600 $166.62
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
19,400 2024-02-26 No 4 A Direct
600 2024-02-26 No 4 A Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.0708 to $166.2075, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
  2. These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in four equal annual installments on the anniversary of the grant date, February 27, 2014.
  3. These two options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these two options vest over four years measured from the grant date, February 27, 2014, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.